Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2024 Sep 16;45(1):9.
doi: 10.1007/s10875-024-01791-w.

Diverse Clinical and Immunological Profiles in Patients with IPEX Syndrome: a Multicenter Analysis from Turkey

Hayrunnisa Bekis Bozkurt  1 , Feyza Bayram Catak  2   3   4 , Ali Sahin  5 , Ezgi Yalcin Gungoren  2   3   4 , Betul Gemici Karaarslan  6 , Nalan Yakici  7 , Melek Yorgun Altunbas  2   3   4 , Mehmet Cihangir Catak  2   3   4 , Salim Can  2   3   4 , Razin Amirov  2   3   4 , Selcen Bozkurt  2   3   4 , Necmiye Ozturk  2   3   4 , Sevgi Bilgic Eltan  2   3   4 , Nurhan Kasap  1 , Fatma Bal Cetinkaya  1 , Fazil Orhan  7 , Mustafa Arga  1 , Ozlem Cavkaytar  1 , Ayca Kiykim  6 , Elif Karakoc-Aydiner  2   3   4 , Ahmet Ozen  2   3   4 , Safa Baris  8   9   10
Affiliations
Multicenter Study

Diverse Clinical and Immunological Profiles in Patients with IPEX Syndrome: a Multicenter Analysis from Turkey

Hayrunnisa Bekis Bozkurt et al. J Clin Immunol. .

Abstract

Purpose: Immunodysregulation, Polyendocrinopathy, Enteropathy, and X-linked syndrome (IPEX), caused by pathogenic FOXP3 variants, is a rare autoimmune disorder with diverse clinical features, including early-onset diabetes, eczema, and enteropathy. Atypical cases show milder symptoms and unique signs, requiring different treatments. Therefore, there are ambiguities in the accurate diagnosis and management of IPEX. We sought to present clinical, genetic, and immunological assessments of 12 IPEX patients with long-term follow-up to facilitate the diagnosis and management of the disease.

Methods: Clinical findings and treatment options of the patients were collected over time. Lymphocyte subpopulations, protein expressions, regulatory T (Treg) and circulating T follicular helper (cTFH) cells, and T-cell proliferation were analyzed.

Results: Predominant presentations included autoimmunity (91.6%), failure to thrive (66.7%), and eczema (58.3%). There were four classical and eight atypical IPEX individuals. Allergic manifestations were more common in atypical patients. Notably, chronic diarrhea demonstrated heightened severity compared to other manifestations. Four patients (33.3%) demonstrated eosinophilia, and nine (75%) showed high serum IgE levels. Most patients exhibited normal percentages of Treg cells with reduced CD25, FOXP3, and CTLA-4 expressions, corrected after hematopoietic stem cell transplantation (HSCT). Compared to healthy controls, the TH2-like skewing accompanied by reduced TH17-like responses was observed in cTFH and Treg cells of patients. Overall, nine patients (75%) received immunosuppressants (ISs), and six (50%) underwent HSCT, which was the only treatment revealing sustained control. Sirolimus was used in six patients and showed better control than other ISs.

Conclusions: The first cohort from Turkey with long-term follow-up results, comparing typical and atypical cases, provides insights into the outcomes of different therapeutic modalities and T- cell subtype changes in IPEX syndrome.

Keywords: Atypical phenotype; Hematopoietic stem cell transplantation; IPEX syndrome; Immunosuppressants; Outcome.

PubMed Disclaimer

References

    1. Gambineri E, CiulliniMannurita S, Hagin D, Vignoli M, Anover-Sombke S, DeBoer S, et al. Clinical, Immunological, and molecular heterogeneity of 173 patients with the phenotype of immune dysregulation, polyendocrinopathy, enteropathy, X-Linked (IPEX) syndrome. Front Immunol. 2018;9:2411. - PubMed - PMC - DOI
    1. Bousfiha A, Moundir A, Tangye SG, Picard C, Jeddane L, Al-Herz W, et al. The 2022 update of IUIS phenotypical classification for human inborn errors of immunity. J Clin Immunol. 2022;42(7):1508–20. - PubMed - DOI
    1. Baris S, Abolhassani H, Massaad MJ, Al-Nesf M, Chavoshzadeh Z, Keles S, et al. The Middle East and North Africa Diagnosis and management guidelines for inborn errors of immunity. J Allergy Clin Immunol Pract. 2023;11(1):158-80.e11. - PubMed - DOI
    1. Agakidis C, Agakidou E, Sarafidis K, Papoulidis I, Xinias I, Farmaki E. Immune dysregulation, polyendocrinopathy, enteropathy, x-linked syndrome associated with a novel mutation of FOXP3 gene. Front Pediatr. 2019;7:20. - PubMed - PMC - DOI
    1. Barzaghi F, Passerini L. IPEX syndrome: improved knowledge of immune pathogenesis empowers diagnosis. Front Pediatr. 2021;9:612760. - PubMed - PMC - DOI

Publication types

MeSH terms

Substances

Supplementary concepts

LinkOut - more resources